WED-207 Non-invasive biomarkers of liver fibrosis may be used for diagnosing fibrosis and prognostication in patients with metabolic dysfunction-associated steatotic liver disease

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Hepatology

Topics

Medicine

Epidemiology

Pathology

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1016/s0168-8278(24)01550-2